These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 9788826)
1. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Li YY; Feldman AM; Sun Y; McTiernan CF Circulation; 1998 Oct; 98(17):1728-34. PubMed ID: 9788826 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Li YY; Feng Y; McTiernan CF; Pei W; Moravec CS; Wang P; Rosenblum W; Kormos RL; Feldman AM Circulation; 2001 Sep; 104(10):1147-52. PubMed ID: 11535571 [TBL] [Abstract][Full Text] [Related]
3. Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy. Thomas CV; Coker ML; Zellner JL; Handy JR; Crumbley AJ; Spinale FG Circulation; 1998 May; 97(17):1708-15. PubMed ID: 9591765 [TBL] [Abstract][Full Text] [Related]
4. Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells. Li YY; McTiernan CF; Feldman AM Cardiovasc Res; 1999 Apr; 42(1):162-72. PubMed ID: 10435007 [TBL] [Abstract][Full Text] [Related]
5. Fibrosis in endstage human heart failure: severe changes in collagen metabolism and MMP/TIMP profiles. Polyakova V; Loeffler I; Hein S; Miyagawa S; Piotrowska I; Dammer S; Risteli J; Schaper J; Kostin S Int J Cardiol; 2011 Aug; 151(1):18-33. PubMed ID: 20546954 [TBL] [Abstract][Full Text] [Related]
6. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223 [TBL] [Abstract][Full Text] [Related]
7. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283 [TBL] [Abstract][Full Text] [Related]
8. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation. Rouet-Benzineb P; Buhler JM; Dreyfus P; Delcourt A; Dorent R; Perennec J; Crozatier B; Harf A; Lafuma C Eur J Heart Fail; 1999 Dec; 1(4):337-52. PubMed ID: 10937947 [TBL] [Abstract][Full Text] [Related]
9. Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling. Wei Y; Cui C; Lainscak M; Zhang X; Li J; Huang J; Zhang H; Zheng Z; Hu S J Cell Mol Med; 2011 Apr; 15(4):773-82. PubMed ID: 20219015 [TBL] [Abstract][Full Text] [Related]
10. Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Elmore JR; Keister BF; Franklin DP; Youkey JR; Carey DJ Ann Vasc Surg; 1998 May; 12(3):221-8. PubMed ID: 9588507 [TBL] [Abstract][Full Text] [Related]
11. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell. Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950 [TBL] [Abstract][Full Text] [Related]
12. Differential regulation of glomerular gelatinase B (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in obese Zucker rats. Schaefer L; Han X; August C; Matzkies F; Lorenz T; Schaefer RM Diabetologia; 1997 Sep; 40(9):1035-43. PubMed ID: 9300240 [TBL] [Abstract][Full Text] [Related]
13. Upregulation of lysyl oxidase and MMPs during cardiac remodeling in human dilated cardiomyopathy. Sivakumar P; Gupta S; Sarkar S; Sen S Mol Cell Biochem; 2008 Jan; 307(1-2):159-67. PubMed ID: 17849172 [TBL] [Abstract][Full Text] [Related]
14. Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat. Peterson JT; Li H; Dillon L; Bryant JW Cardiovasc Res; 2000 May; 46(2):307-15. PubMed ID: 10773235 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of doxycycline, losartan, and their combination on the expression of matrix metalloproteinase, tissue inhibitor of matrix metalloproteinase, and collagen remodeling in the noninfarcted myocardium after acute myocardial infarction in rats]. Zhang P; Yang YJ; Chen X; Ruan YM; Zhou YW; Tian Y; Chen ZJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):53-61. PubMed ID: 15782494 [TBL] [Abstract][Full Text] [Related]
18. Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis. Kossakowska AE; Edwards DR; Lee SS; Urbanski LS; Stabbler AL; Zhang CL; Phillips BW; Zhang Y; Urbanski SJ Am J Pathol; 1998 Dec; 153(6):1895-902. PubMed ID: 9846979 [TBL] [Abstract][Full Text] [Related]
19. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Curry TE; Song L; Wheeler SE Biol Reprod; 2001 Sep; 65(3):855-65. PubMed ID: 11514351 [TBL] [Abstract][Full Text] [Related]